Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.
PLoS One
; 18(2): e0281993, 2023.
Article
en En
| MEDLINE
| ID: mdl-36800368
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vacunas contra la COVID-19
/
COVID-19
Límite:
Adolescent
/
Adult
/
Aged
/
Child
/
Child, preschool
/
Humans
/
Middle aged
País como asunto:
America do norte
Idioma:
En
Año:
2023
Tipo del documento:
Article